References
Williams T. The mechanism of action of isothiazolinone biocides. Powerplant Chem 2007; 9: 14–22.
Aerts O, Goossens A, Lambert A, Lepoittevin JP. Contact allergy caused by isothiazolinone derivatives: an overview of non-cosmetic and unusual cosmetic sources. Eur J Dermatol 2017; 27: 115–22.
Thierauf J, Veit JA, Hess J, et al. Checkpoint inhibition for advanced mucosal melanoma. Eur J Dermatol 2017; 27: 160–5.
Topalian SL, Hodi FS, Brahmer JR, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012; 366: 2443–54.
Hino R, Kabashima K, Kato Y, et al. Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma. Cancer 2010; 116: 1757–66.
Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012; 12: 252–64.
Senger P, Abidi N, Lin DM, Seiffert-Sinha K, Sinha A. Positive correlation of anti-herpes simplex type I virus antibody levels with pemphigus vulgaris disease status and activity in a large patient cohort. Eur J Dermatol 2017; 27:160–5.
Bystryn JC, Rudolph JL. Pemphigus. Lancet 2005; 366: 61–73.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Frings, V., Fattouh, K., Hernandez-Aragues, I. et al. Residents’corner, March–April 2017. Editorial: What’s new this month?. Eur J Dermatol 27, 214–215 (2017). https://doi.org/10.1684/ejd.2017.3000
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2017.3000